The significance of chirality in contemporary drug discovery-a mini review

Narmatha Senkuttuvan,Boopathi Komarasamy,Rajavenkatesh Krishnamoorthy,Shuvajyoti Sarkar,Sivasankaran Dhanasekaran,Parthiban Anaikutti
DOI: https://doi.org/10.1039/d4ra05694a
2024-10-22
Abstract:More than half of drugs are chiral compounds with their chirality determining their molecular interactions, ecofriendly environmental safety and efficacy. Overall nearly 90% of chiral compounds are marketed as racemates consisting of an equimolar mixture of two enantiomers. Despite having identical chemical structure and bonding, racemates function differently when exposed to chiral environments and demonstrate notable variances in biological properties such as pharmacology, toxicology, metabolism and pharmacokinetics, etc. Advancements in asymmetric synthesis in recent years have led to considerable interest in the development of single enantiomers of chiral drug molecules for medicinal chemistry settings. In this review, we want to compile examples of chiral medicines approved by the FDA in the years 2022 and 2023 with an emphasis on their synthesis along with information on chiral induction as well as enantiomeric excess.
What problem does this paper attempt to address?